Distributing Scientific and Medical Publications on Risk Information for Approved Prescription Drugs and Biological Products—Recommended Practices
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 11, 2014
April 16, 2020
69e4b507-d287-4a18-8387-90dfb7cd1805
Related Documents
Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices
Guidance DocumentJune 18, 2014Center for Drug Evaluation and Research
Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs
Guidance DocumentAugust 6, 2015Center for Drug Evaluation and Research
Drug Interaction Information in Human Prescription Drug and Biological Product Labeling
Guidance DocumentOctober 21, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.